Seaport Therapeutics, Inc. ($SPTX)
Filing Information
| Accession Number | 0001193125-26-204458 |
|---|---|
| Form Type | 4 |
| Filing Date | May 4, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
11,489,902
Total Value
$19,800,000.00
P&L
-5.6% ($1,100,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | May 4, 2026 | Conversion | 2,513,686 | โ | โ | 2,513,686 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Common Stock | โ | May 4, 2026 | Conversion | 2,681,265 | โ | โ | 5,194,951 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Common Stock | โ | May 4, 2026 | Purchase | 1,100,000 | $18.00 | $19,800,000.00 | 6,294,951 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Series A-2 Preferred Stock | Derivative | May 4, 2026 | Conversion | 2,513,686 | $0.00 | $0.00 | 0 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Series B Preferred Stock | Derivative | May 4, 2026 | Conversion | 2,681,265 | $0.00 | $0.00 | 0 | Indirect | By ARCH Venture Fund XII, L.P. | View Details |